Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of squalene against inflammation
- PMID: 38756678
- PMCID: PMC11093945
- DOI: 10.1007/s40203-024-00217-0
Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of squalene against inflammation
Abstract
Squalene (SQ) has been documented in the past for its ability to reduce inflammation, but its mechanism needs more information. In this study, we investigated squalene as an anti-inflammatory drug candidate and the framework involved in treating inflammation (INF) using the network pharmacology concept. The molecular targets of SQ and INF that are available in databases and the overlaps between these targets were demonstrated using InteractiVenn. The protein-protein networks were generated that in turn revealed several key targets and were further processed with Cytoscape. The gene ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) studies were performed. We also performed molecular docking tests that validated the binding affinity of molecular targets and drugs. A total of 100 SQ targets and 11,417 INF-related targets yielded 93 overlapping targets. Seven core targets, CRHR1, EGFR, ERBB2, HIF1A, SLC6A3, MAP2K1, and F2R were found to be relevant with respective to SQ's anti-inflammatory activity. The underlying mechanism of SQ with regard to INF was interpreted by analyzing various enrichment analyses along with the KEGG pathway. In conclusion, SQ played a vital role in the management of INF by regulating CRHR1, EGFR, ERBB2, HIF1A, SLC6A3, MAP2K1, and F2R. The research outcomes are crucial as they offer significant insights into the use of SQ for combating inflammation.
Supplementary information: The online version contains supplementary material available at 10.1007/s40203-024-00217-0.
Keywords: Anti-inflammatory; Drug mechanism, protein-protein interaction; Inflammation; Network pharmacology; Squalene.
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Competing interestsThe authors declare no competing interests.
Similar articles
-
Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.Comb Chem High Throughput Screen. 2022;25(10):1785-1804. doi: 10.2174/1386207325666220523151119. Comb Chem High Throughput Screen. 2022. PMID: 35616676
-
Research on the Mechanism of Guizhi to Treat Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking Technology.Biomed Res Int. 2021 Nov 27;2021:8141075. doi: 10.1155/2021/8141075. eCollection 2021. Biomed Res Int. 2021. PMID: 34873575 Free PMC article.
-
Unveiling the potential mechanisms of Amomi fructus against gastric ulcers via integrating network pharmacology and in vivo experiments.J Ethnopharmacol. 2024 Jan 30;319(Pt 2):117179. doi: 10.1016/j.jep.2023.117179. Epub 2023 Sep 29. J Ethnopharmacol. 2024. PMID: 37777029
-
Network pharmacology, molecular docking, combined with experimental verification to explore the role and mechanism of shizhifang decoction in the treatment of hyperuricemia.Heliyon. 2024 Jan 25;10(3):e24865. doi: 10.1016/j.heliyon.2024.e24865. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38322942 Free PMC article.
-
Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology.Comput Biol Chem. 2021 Feb;90:107358. doi: 10.1016/j.compbiolchem.2020.107358. Epub 2020 Aug 8. Comput Biol Chem. 2021. PMID: 33243703 Review.
References
-
- Aisa Y, Yunusi K, Chen Q, Mi N. Systematic understanding of the potential targets and pharmacological mechanisms of acteoside by network pharmacology approach. Med Chem Res. 2020;29(4):793–801. doi: 10.1007/S00044-020-02524-5. - DOI
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous